Medicine prices at risk under Pacific trade draft: critics The U.S. experience, where generic drugs made up 85 percent of the market, showed that high IP standards were compatible with “fulsome access to medicines,” said Mark Elliot from the U.S. Chamber of Commerce’s Global Intellectual Property Center. But Northeastern University law professor Brook Baker said there were several proposals in the draft which would […]